Comparison treatment of magnesium sulfate for 12-hours and 24-hours in preeclampsia
Phase 3
- Conditions
- Preeclampsia.
- Registration Number
- IRCT20200503047287N1
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Preeclampsia
Blood pressure 140/90 mm Hg or higher after 20 weeks of gestation
Proteinuria with a rate of one plus or more
Exclusion Criteria
?Eclampsia
HELLP Syndrome
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method High blood pressure. Timepoint: Hospitalization time and every one hour during magnesium sulfate treatment. Method of measurement: The patient's systolic and diastolic blood pressure is measured every hour by a standard sphygmomanometer.
- Secondary Outcome Measures
Name Time Method Incidence of seizures: Incidence of involuntary repetitive movements, Complications of magnesium sulfate: which is assessed by spinal reflexes through the patellar reflex, assessment of the number of breaths per minute and the amount of urine collected in the urinbag. Timepoint: Urine output is measured every hour with a Foley catheter. Method of measurement: Using a Foley catheter.